These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9757171)

  • 1. Secrecy and the health protection branch.
    Lexchin J
    CMAJ; 1998 Sep; 159(5):481-3. PubMed ID: 9757171
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 3. Secrecy and transparency of medicines licensing in the EU.
    Abraham J; Lewis G
    Lancet; 1998 Aug; 352(9126):480-2. PubMed ID: 9708771
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug information resources for health professionals and consumers.
    Durkin C
    Natl Netw; 1998 Feb; 22(3):10-1. PubMed ID: 10176590
    [No Abstract]   [Full Text] [Related]  

  • 5. Full clinical trial disclosure needed: expert.
    Silversides A
    CMAJ; 2006 Jul; 175(2):140. PubMed ID: 16847272
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug detailing in the hospital: background for policy development.
    Chan J; Einarson T
    Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744
    [No Abstract]   [Full Text] [Related]  

  • 7. Getting SMART (submission management and review tracking) drug review in the computer age.
    Flieger K
    FDA Consum; 1995 Oct; 29(8):6-9. PubMed ID: 10151839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.
    Kesselheim AS; Mello MM
    Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of drug information service provided by pharmaceutical manufacturers.
    Doyal LE
    Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
    [No Abstract]   [Full Text] [Related]  

  • 11. Information responsibilities of generic drug companies.
    Cramer R
    Am J Hosp Pharm; 1986 Jul; 43(7):1674, 1679. PubMed ID: 3752098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Can we rely on drug information?].
    Myhr K
    Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198
    [No Abstract]   [Full Text] [Related]  

  • 13. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 14. Piercing the veil of corporate secrecy about clinical trials.
    Lemmens T
    Hastings Cent Rep; 2004; 34(5):14-8. PubMed ID: 15553393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical secrecy].
    Bernard MH; Canas F
    Rev Prat; 2001 May; 51(9):1008-15. PubMed ID: 11458601
    [No Abstract]   [Full Text] [Related]  

  • 16. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

  • 17. Internet strategies being implemented by pharmaceutical companies.
    Goldstein D; Flory J
    Med Interface; 1997 May; 10(5):48-50. PubMed ID: 10167503
    [No Abstract]   [Full Text] [Related]  

  • 18. How to think about medical secrecy.
    Glenn HP
    Health Law Can; 1998 Aug; 19(1):27-9. PubMed ID: 10345086
    [No Abstract]   [Full Text] [Related]  

  • 19. Hear no secrets, see no secrets, speak no secrets: secrecy in the Canadian drug approval system.
    Lexchin J
    Int J Health Serv; 1999; 29(1):167-78. PubMed ID: 10079402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disclosure at Pfizer Canada.
    Prigent BM
    CMAJ; 2002 Oct; 167(8):847; author reply 847. PubMed ID: 12406935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.